Viruez-Soto JA, Briones-Garduño JC, Díaz de León-Ponce MA, Briones-Vega CG

Language: Spanish
References: 8
Page: 216-220
PDF size: 191.11 Kb.

ABSTRACT

Objective: To determinate the effect of the administration of inotropic in severe preeclampsia with hypodynamic pattern.
Design: Prospective longitudinal case-control study.
Field: Gynecology and obstetrics critical care unit of the Hospital General de México «Dr. Eduardo Liceaga» in México D.F., during the period 14 May-14 July 2014.
Patients and methods: Patients with diagnosis of severe preeclampsia with hypodynamic (n = 14) and eudynamic pattern (n = 12).
Results: With thoracic bioimpedance, the hemodynamics variables were measured, before and after the respective treatment for severe preeclampsia, including inotropic in the hypodynamic group. The cardiac output increased 51% in the «hypodynamic group» and 6% in the «control group» (p ‹ 0.05, both of them), with a reduction in the mean arterial pressure in the «hypodynamic group» of 20% and in the «control group» of 12% (p ‹ 0.05, both of them).
Discussion and conclusions: The administration of inotropic optimizes the cardiac output in severe preeclampsia with hypodynamic pattern and allows a better control of the mean arterial pressure.

REFERENCES

1. Briones-Garduño JC, Castro-Ñuco J, Díaz de León-Ponce MA, Briones-Vega CG. Monitoreo hemodinámico con bioimpedancia torácica en pacientes con preeclampsia severa. Rev Asoc Mex Med Crit y Ter Int. 2012;26(4):201-208.

2. Meneses-Calderón J, Díaz de León-Ponce M, Moreno-Santillán AA, Iván-González-Díaz JI, Amezola-Ceballos MA, Jiménez-Arroyo EP et al. Medición de valores hemodinámicos en embarazo normoevolutivo y puerperio inmediato por bioimpedancia torácica. Rev Asoc Mex Med Crit y Ter Int. 2007;21(3):149-153.

3. Meneses-Calderón J, Moreno-Santillán AA, González-Díaz JI, Díaz de León-Ponce MA, Rodríguez-Roldán M, Castorena de Ávila R et al. Medición hemodinámica en preeclampsia severa. Rev Asoc Mex Med Crit y Ter Int. 2008;22(1):10-14.

4. Pathak A, Lebrin M, Vaccaro A, Senard JM, Despas F. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects. Journal of Clinical Pharmacy and Therapeutics. 2013;38:341-349.

5. Bhattacharyya A, Singh-Basra S, Sen P, Kar B. Peripartum cardiomyopathy, Tex Heart Inst J. 2012;39(1):8-16.

6. Pires-Duarte F, O’Neill P, Centeno MJ, Ribeiro I, Moreira J. Infarto agudo de miocardio en la 31ª semana de embarazo-relato de caso. Rev Bras Anestesiol. 2011;61(2):121-123.

7. Carrillo-Esper R, Sánchez-Zuñiga MJ. Digitálicos. En: Gutiérrez-Lizardi P, Carrillo-Esper R, Gutiérrez-Jiménez P, et al. Guía farmacológica en la UCIA. México, D.F.: McGraw-Hill; 2010. p. 74-80.

8. Carrillo-Esper R, Contreras-Domínguez V, Sánchez-Zuñiga MJ. Fármacos vasoactivos. En: Gutiérrez-Lizardi P, Carrillo-Esper R, Gutiérrez-Jiménez P et al. Guía farmacológica en la UCIA. México, D.F.: McGraw-Hill; 2010. p. 88-105.